CD44 and head and neck squamous cell carcinoma: In this study, we hypothesized that locally advanced HNSCC with a high percentage of cells with pan-CK or HLA-I markers or a low percentage of cells with p-EGFR or CD44 markers would have better clinical outcomes after curative treatment (surgery followed by adjuvant therapy).